CEA ELISA(Pathozyme® CEA ELISA)
- UID
- IMP/IVD/2018/000005_a5d6e7f6c40d22d73cf6217461eeb3b6_6095bbc512e638dc575c4276a85bce11
- Device class
- Class C
- Brand name
- Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA
- License holder
- Omega DX (Asia) Private Limited
- Approving authority
- CDSCO
- Product information
- Pathozyme® CEA (Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA) ELISA is an in-vitro diagnostic kit used for the quantitative determination of Carcinoembryonic Antigen (Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA)in human serum
CEA ELISA(Pathozyme® CEA ELISA) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2018/000005_a5d6e7f6c40d22d73cf6217461eeb3b6_6095bbc512e638dc575c4276a85bce11. This device is marketed under the brand name Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA. The license holder is Omega DX (Asia) Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.